For example, cotreatment of erlotinib and an IGF1R inhibitor induced both apoptosis and cell cycle arrest, while single agent of either inhibitor alone only induce cell cycle arrest in some EGFR mutant NSCLC cells [32]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.